" class="no-js "lang="en-US"> Bill Frist - Medtech Alert
Tuesday, February 24, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Bill Frist

Bill Frist

About Bill Frist

A leading authority on healthcare and former U.S. Senate Majority Leader. Sen. Frist is a nationally recognized surgeon, co-founder and partner at Frist Cressey Ventures, and founder of Aspire Health.

Related Story

Diseases

 Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease | Pharmtech Focus

Monogram Health Donates $2.5M to University of Pennsylvania for Clinical Research Partnership Aimed at Improving Outcomes for People with Chronic Kidney Disease

September 14 2022

Monogram Health, the leading value-based specialty provider of in-home nephrology, primary care, and benefit management […]